Views & Analysis | Perspectives on pharma industry issues

Digital

Abstract AI concept, turquoise hexagonals on dark background

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

R&D

A certificate of analysis should be evidence, not a sales do...

Regulators weighing peptide bulk substances can ask whether today's documentation rules fit the risks of this supply chain.

R&D

From phase 1 to phase 3: Scaling radiopharmaceutical trials

Success in radiopharmaceutical development depends on creating and maintaining an integrated, scalable system.

Patients

pharmaphorum podcast Episode 285, Donna Cryer, CryerHealth, LLC

Patients not just at the table, but creating their own: In c...

Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.

R&D

Gravity is an experimental variable pharma has rarely been a...

Microgravity should not be a destination for pharmaceutical R&D, but another experimental environment.

Articles

Amit Gupta needs you!

Moved by the story of a young entrepreneur with leukaemia, we speak to Seth Godin to find out how Amit Gupta is shaking the world with his online campaign for bone marrow donors. Last week pharmaphorum heard about the story of Amit Gupta, a young entrepreneur living in San Francisco, who has just discovered that he has acute leukaemia…

Articles

NHS and pharma: evidence, value and collaboration

Ashish Rishi investigates the evolving relationship of the NHS and pharma. As the NHS tries to claw back a £20 billion deficit over the next 4 years, we will see a number of fundamental changes to the way we...

Articles

Managing clinical trial fraud

Darshan Kulkarni discusses clinical trial fraud in the first of his series in which he will provide insights on the legal, regulatory, administrative and ethical issues that can affect the pharmaceutical industry. There have been numerous instances of fraud on Sponsors in the context of clinical trials. This fraud may be caused by CROs...

Sales & Marketing

Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Digital

Sponsored

The hardest part of becoming an AI-first company: It’s not t...

Axtria president and CEO Jaswinder Chadha on the culture and governance decisions behind his company’s AI transformation.

Digital

Sponsored

Antiviral development in the age of AI: From pre-IND to earl...

hVIVO experts discuss how advancements in AI and machine learning are pushing industry beyond the bounds of a traditional "one virus, one drug" model.